EU | EMA Adds New RWD Q&A — Reinforcing ICH M14 Expectations for Non-Interventional Studies Using Real-World Data GalleryEU | EMA Adds New RWD Q&A — Reinforcing ICH M14 Expectations for Non-Interventional Studies Using Real-World Data
2026, EMA, EU, May 2026, Members-Only, Moderate Update, RWD to Support Reg Decisions, Secondary Use of Existing Data-
CHINA | NEW BIOMEDICAL TECHNOLOGIES REGULATION TAKES EFFECT — CREATING A NATIONAL FRAMEWORK FOR CLINICAL RESEARCH, TRANSLATIONAL APPLICATION AND LONG-TERM SAFETY OVERSIGHT GalleryCHINA | NEW BIOMEDICAL TECHNOLOGIES REGULATION TAKES EFFECT — CREATING A NATIONAL FRAMEWORK FOR CLINICAL RESEARCH, TRANSLATIONAL APPLICATION AND LONG-TERM SAFETY OVERSIGHT
-
BRAZIL | INAEP Issues New Operational Guidance to Implement Law No. 14,874/2024 — Strengthening CEP Governance, Review Timelines and SINEP Standardisation GalleryBRAZIL | INAEP Issues New Operational Guidance to Implement Law No. 14,874/2024 — Strengthening CEP Governance, Review Timelines and SINEP Standardisation
-
Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations GallerySingapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations
-
